alpha-fluoromethylhistidine has been researched along with Acute Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Fang, Q; Hou, WW; Lou, GD; Ohtsu, H; Shou, WT; Tang, YY; Xu, TL; Yu, J; Yue, JX; Zhang, SH | 1 |
1 other study(ies) available for alpha-fluoromethylhistidine and Acute Disease
| Article | Year |
|---|---|
Histamine modulation of acute nociception involves regulation of Nav 1.8 in primary afferent neurons in mice.
Topics: Action Potentials; Acute Disease; Animals; Ganglia, Spinal; Histamine; Histidine Decarboxylase; Methylhistidines; Mice; NAV1.8 Voltage-Gated Sodium Channel; Neurons, Afferent; Nociception; Tetrodotoxin | 2013 |